STOCK TITAN

State Street (BMY holder) discloses 5% Bristol-Myers Squibb ownership

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

State Street Corporation reports a significant ownership position in Bristol-Myers Squibb common stock. State Street beneficially owns 102,521,748 shares, representing 5% of the class as of June 30, 2026. It has no sole voting or dispositive power, but holds shared voting power over 64,032,454 shares and shared dispositive power over 102,408,940 shares. The position is held through various investment adviser subsidiaries, including SSGA Funds Management, Inc. and multiple State Street Global Advisors entities in the U.S., Europe, Asia, Australia, Singapore and Saudi Arabia.

Positive

  • None.

Negative

  • None.
Beneficial ownership 102,521,748 shares Bristol-Myers Squibb common stock beneficially owned by State Street as of June 30, 2026
Percent of class 5 % Percentage of Bristol-Myers Squibb common stock class owned by State Street
Shared voting power 64,032,454 shares Shares over which State Street has shared power to vote or direct the vote
Shared dispositive power 102,408,940 shares Shares over which State Street has shared power to dispose or direct disposition
Sole voting power 0 Shares over which State Street has sole power to vote or direct the vote
Sole dispositive power 0 Shares over which State Street has sole power to dispose or direct disposition
beneficially owned financial
"Amount beneficially owned: 102521748.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 64,032,454.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 102,408,940.00"
parent holding company financial
"If a parent holding company has filed this schedule"
Investment Company Act of 1940 regulatory
"investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does State Street hold in Bristol-Myers Squibb (BMY)?

State Street Corporation beneficially owns 102,521,748 shares of Bristol-Myers Squibb common stock, representing 5% of the outstanding class as of June 30, 2026.

How much voting power does State Street have in Bristol-Myers Squibb (BMY)?

State Street reports no sole voting power and shared voting power over 64,032,454 shares of Bristol-Myers Squibb common stock, reflecting votes controlled collectively with clients or affiliates.

What dispositive power does State Street have over BMY shares?

State Street has no sole dispositive power but holds shared dispositive power over 102,408,940 shares of Bristol-Myers Squibb, meaning it can direct the disposition of these shares with others.

Which State Street subsidiaries are involved in managing the Bristol-Myers Squibb (BMY) stake?

The stake is managed through investment adviser subsidiaries including SSGA Funds Management, Inc. and several State Street Global Advisors entities across the U.S., Europe, Asia, Australia, Singapore and Saudi Arabia.

Is State Street part of a reporting group for its Bristol-Myers Squibb (BMY) holdings?

The filing indicates no applicable group arrangement for this position, stating that identification and classification of members of a group are not applicable.

Do others have rights to dividends or sale proceeds from State Street’s BMY holdings?

The disclosure under Item 6 states "NOT APPLICABLE", indicating no separately identified person is reported as having rights to dividends or sale proceeds above the 5% threshold.





110122108

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



STATE STREET CORPORATION
Signature:ELIZABETH SCHAEFER
Name/Title:SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:08/07/2026